LY2157299
Showing 1 - 21 of 21
Prostate Cancer Trial in Washington, Chicago, Baltimore (Enzalutamide, LY2157299)
Recruiting
- Prostate Cancer
- Enzalutamide
- LY2157299
-
Washington, District of Columbia
- +3 more
Jun 1, 2022
Rectal Adenocarcinoma Trial in Portland (LY2157299, Capecitabine, Fluorouracil)
Active, not recruiting
- Rectal Adenocarcinoma
- LY2157299
- +3 more
-
Portland, OregonProvidence Cancer Center
Mar 22, 2022
ADVANCED HEPATOCELLULAR CARCINOMA (HCC) Trial in Philadelphia (Galunisertib 150mg by mouth twice a day, Stereotactic Body
Completed
- ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
- Galunisertib 150mg by mouth twice a day
- Stereotactic Body Radiotherapy (SBRT)
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Mar 10, 2022
Glioblastoma Trial in Worldwide (LY2157299 monohydrate, Lomustine, Placebo)
Active, not recruiting
- Glioblastoma
- LY2157299 monohydrate
- +2 more
-
Birmingham, Alabama
- +26 more
Oct 18, 2022
Hepatocellular Carcinoma Trial in Worldwide (LY2157299, Sorafenib, Placebo)
Completed
- Hepatocellular Carcinoma
- LY2157299
- +2 more
-
Beijing, China
- +15 more
Feb 14, 2022
Metastatic Breast Cancer Trial in New York (Radiation therapy, Study Drug)
Terminated
- Metastatic Breast Cancer
- Radiation therapy
- Study Drug
-
New York, New YorkWeill Cornell Medical College
Nov 20, 2019
Carcinoma, Hepatocellular Trial in Worldwide (LY2157299, Sorafenib, Ramucirumab)
Completed
- Carcinoma, Hepatocellular
- LY2157299
- +2 more
-
Fayetteville, Arkansas
- +39 more
Dec 21, 2020
Metastatic Pancreatic Cancer Trial in Worldwide (Galunisertib, Durvalumab)
Completed
- Metastatic Pancreatic Cancer
-
Scottsdale, Arizona
- +10 more
Aug 2, 2019
Colorectal Cancer Metastatic Trial in Amsterdam (Galunisertib)
Withdrawn
- Colorectal Cancer Metastatic
-
Amsterdam, Noord-Holland, NetherlandsAntoni van Leeuwenhoek (NKI-AVL)
Jul 22, 2019
MDS Trial in Germany, Italy, Spain (Galunisertib, Placebo)
Myeloproliferative Tumor Trial in New York (Vactosertib)
Recruiting
- Myeloproliferative Neoplasm
-
New York, New YorkWeill Medical College of Cornell University
Dec 20, 2021
Tumor Trial in New York City (Galunisertib)
Completed
- Neoplasm
-
New York City, New YorkMemorial Sloan Kettering Cancer Center
Oct 4, 2016
Glioma Trial in Germany, Spain, United States (LY2157299, Radiation, Temozolomide)
Completed
- Glioma
- LY2157299
- +2 more
-
La Jolla, California
- +9 more
Feb 15, 2017
Healthy Trial in Leeds (Galunisertib)
Completed
- Healthy
-
Leeds, West Yorkshire, United KingdomFor additional information regarding investigative sites for thi
Jun 30, 2016
Tumors, Tumor Metastasis Trial in Tokyo (LY2157299)
Completed
- Neoplasms
- Neoplasm Metastasis
- LY2157299
-
Tokyo, JapanFor additional information regarding investigative sites for thi
Jun 30, 2014
Healthy Volunteers Trial in Daytona Beach (LY2157299)
Completed
- Healthy Volunteers
- LY2157299
-
Daytona Beach, FloridaFor additional information regarding investigative sites for thi
Dec 3, 2013
Healthy Volunteers Trial in Madison ([^14C]-LY2157299)
Completed
- Healthy Volunteers
-
Madison, WisconsinFor additional information regarding investigative sites for thi
Feb 14, 2013